ACHC Stock Cash Flow Statements

Acadia Healthcare Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Acadia Healthcare Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31

operating activities:
net income	37,936,000	9,064,000	33,529,000	71,368,000	80,817,000	78,770,000	59,757,000	-215,525,000	73,549,000	66,558,000	63,145,000	73,046,000	81,932,000	61,910,000	71,519,000	67,900,000	45,664,000	10,479,000	-782,541,000	37,561,000	41,714,000	34,067,000	-10,313,000	42,723,000	48,201,000	29,511,000	-331,529,000	46,279,000	58,890,000	50,874,000	69,689,000	45,489,000	49,638,000	34,773,000	41,426,000	-118,210,000	55,591,000	25,369,000	33,952,000	29,086,000	33,844,000	14,594,000	25,402,000	22,451,000	13,058,000	12,280,000	14,364,000	12,197,000	3,738,000	4,365,000	6,450,000	5,909,000	3,679,000	-15,909,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	48,995,000	47,032,000	39,541,000	37,641,000	36,066,000	36,347,000	35,380,000	33,388,000	32,012,000	31,569,000	30,142,000	29,573,000	29,128,000	28,926,000	28,368,000	27,805,000	25,650,000	24,894,000	-30,781,000	42,912,000	41,445,000	41,680,000	41,767,000	40,620,000	41,077,000	40,580,000	39,472,000	39,659,000	39,928,000	39,773,000	37,754,000	36,442,000	35,201,000	33,613,000	33,958,000	36,418,000	36,752,000	27,975,000	18,630,000	16,890,000	14,926,000	13,104,000	10,325,000	5,935,000	5,436,000	4,842,000	4,414,000	4,212,000	3,622,000	2,650,000	2,076,000	1,641,000	1,615,000	1,174,000
amortization of debt issuance costs	1,222,000	1,056,000	1,027,000	1,027,000	1,018,000	1,016,000	837,000	834,000	827,000	824,000	821,000	820,000	812,000	808,000	806,000	802,000	817,000	1,646,000	2,940,000	3,314,000	3,332,000	3,050,000	3,061,000	3,039,000	2,999,000	2,888,000	2,693,000	2,639,000	2,599,000	2,525,000	2,515,000	2,495,000	2,449,000	2,396,000	2,610,000	2,758,000	2,809,000	2,147,000	1,692,000	1,799,000	1,750,000	1,468,000	895,000	690,000	644,000	578,000	576,000	570,000	540,000	638,000	645,000	637,000	587,000	587,000
equity-based compensation expense	10,549,000	8,677,000	10,099,000	9,467,000	8,869,000	8,678,000	9,149,000	8,163,000	7,348,000	7,629,000	7,890,000	7,240,000	6,580,000	7,925,000	12,542,000	8,923,000	9,031,000	7,034,000	6,246,000	5,471,000	5,808,000	4,979,000	2,985,000	4,039,000	4,182,000	6,101,000	2,728,000	5,225,000	7,129,000	6,919,000	4,460,000	4,175,000	7,436,000	7,396,000	7,356,000	7,145,000	6,888,000	6,956,000	5,896,000	5,327,000	5,355,000	3,894,000	2,805,000	2,406,000	1,764,000	1,505,000	1,331,000	1,812,000	601,000	576,000	521,000	592,000	578,000	-2,523,000
deferred income taxes	-3,132,000	-5,621,000	11,575,000	17,116,000	21,541,000	17,476,000	-72,329,000	-22,002,000	135,000	212,000	-3,631,000	12,201,000	4,706,000	3,269,000	2,777,000	538,000	4,495,000	3,962,000	11,305,000	19,758,000	10,759,000	11,286,000	-3,370,000	5,355,000	461,000	-666,000	-7,976,000	2,240,000
debt extinguishment costs	0	1,269,000													0	0	0	24,650,000	3,962,000	0							875,000	0	0	940,000	0	0			842,000				839,000							0	0	0	9,350,000
legal settlements expense							0
loss on impairment			5,817,000	10,459,000			1,096,000	0							0	1,079,000			-15,488,000
gain on sale of property
other	1,055,000	73,000	-698,000	-46,000	152,000	-4,094,000	1,745,000	337,000	-3,000	1,089,000	258,000	2,026,000	874,000	-478,000	-390,000	53,000	-909,000	1,737,000	231,000	1,962,000	-1,045,000	-107,000	-409,000	2,049,000	208,000	2,187,000	9,346,000	1,985,000	-3,000	1,043,000	740,000	4,114,000	2,733,000	3,825,000	3,984,000	27,000	-178,000	882,000	493,000	430,000	314,000	378,000	138,000	12,000	13,000	5,000	2,000	-1,000	15,000	6,000	-30,000	2,000	19,000	2,000
change in operating assets and liabilities, net of effect of acquisitions:
accounts receivable	-11,667,000	-30,993,000	18,607,000	5,178,000	-3,184,000	-22,930,000	1,215,000	-16,830,000	571,000	-23,968,000	-6,440,000	-15,775,000	-1,541,000	-18,222,000	11,058,000	4,362,000	-10,482,000	-2,490,000	9,948,000	-5,674,000	13,894,000	-2,828,000	13,896,000	-5,287,000	-15,689,000	-11,980,000	26,431,000	-17,148,000	-7,311,000	-18,793,000	111,000	-6,277,000	-9,945,000	-12,459,000	-3,139,000	6,403,000	-15,233,000	-3,749,000	3,951,000	-18,463,000	-3,485,000	-6,957,000	-10,092,000	-6,609,000	-8,694,000	-2,864,000	-7,821,000	-1,035,000	-9,522,000	2,293,000	-8,407,000	-4,265,000	-6,354,000	-900,000
other current assets	5,222,000	-9,019,000	-4,128,000	10,848,000	1,447,000	-15,629,000	86,045,000	-68,422,000	14,687,000	-23,430,000	11,066,000	-10,586,000	-1,468,000	-16,638,000	4,726,000	29,298,000	-32,131,000	75,000	13,484,000	4,429,000	10,893,000	-19,131,000	2,568,000	6,679,000	-4,716,000	-5,875,000	10,843,000	-6,932,000	23,169,000	-13,216,000	-5,291,000	5,642,000	14,571,000	5,886,000	-7,675,000	-5,717,000	819,000	-8,075,000	9,484,000	847,000	10,710,000	-23,758,000	6,114,000	-5,744,000	952,000	2,005,000	-5,764,000	1,179,000	-1,072,000	5,260,000	-1,463,000	-1,570,000	-644,000	-1,003,000
other assets	-6,470,000	-1,214,000	-155,000	-166,000	146,000	696,000	680,000	631,000	1,114,000	-1,436,000	-1,121,000	823,000	2,752,000	-202,000	5,076,000	-23,122,000	10,846,000	-3,570,000	1,203,000	-2,507,000	3,919,000	-1,096,000	-603,000	-131,000	366,000	295,000	-1,106,000	1,107,000	4,029,000	-1,268,000	-2,610,000	-2,375,000	3,519,000	-1,710,000	-3,220,000	-2,716,000	3,984,000	-2,402,000	-3,142,000	-3,661,000	-582,000	-636,000	-1,508,000	998,000	-1,576,000	-563,000	-869,000	43,000	-850,000	-392,000	716,000	353,000	-40,000
accounts payable and other accrued liabilities	36,926,000	-9,242,000	-15,951,000	-5,323,000	3,721,000	-403,340,000	-5,653,000	1,539,000	7,885,000	13,633,000	-2,555,000	-17,789,000	15,017,000	10,501,000	-194,000	-4,948,000	15,285,000	-3,979,000	-12,759,000	49,829,000	62,678,000	-21,755,000	14,256,000	-24,550,000	4,641,000	-15,701,000	16,824,000	-11,836,000	24,434,000	-3,368,000	16,268,000	-21,488,000	12,100,000	-16,993,000	20,626,000	-27,034,000	21,603,000	7,498,000	15,184,000	-4,003,000	-5,587,000	1,274,000	2,378,000	539,000	-1,839,000	-3,444,000	1,558,000	2,035,000	-997,000	-4,332,000	7,622,000	-6,296,000	3,491,000
accrued salaries and benefits	15,861,000	-19,801,000	13,956,000	6,684,000	16,499,000	-25,024,000	19,570,000	10,851,000	16,497,000	-30,386,000	15,635,000	-11,513,000	2,436,000	246,000	-9,065,000	9,997,000	5,908,000	2,915,000	-6,845,000	17,271,000	5,236,000	-6,030,000	3,007,000	8,045,000	2,617,000	-5,849,000	4,699,000	6,685,000	-438,000	4,802,000	-1,051,000	1,220,000	-5,720,000	-3,437,000	2,187,000	-6,913,000	2,501,000	-6,347,000	-7,230,000	9,113,000	4,797,000	-5,022,000	7,190,000	7,189,000	-5,407,000	6,270,000	902,000	3,122,000	-7,491,000	4,615,000	200,000	1,639,000	-1,312,000	-1,802,000
other liabilities	4,270,000	16,692,000	3,482,000	-1,124,000	3,056,000	6,749,000	-6,908,000	15,155,000	454,000	2,114,000	4,787,000	2,375,000	1,630,000	6,298,000	-3,307,000	-512,000	-6,911,000	-4,210,000	17,309,000	12,731,000	17,494,000	1,431,000	-1,856,000	2,262,000	666,000	2,182,000	-5,368,000	942,000	-1,302,000	509,000	4,117,000	2,420,000	3,115,000	2,142,000	738,000	18,000	3,374,000	354,000	4,165,000	452,000	4,039,000	580,000	2,104,000	931,000	770,000	-357,000	3,080,000	729,000	-271,000	-825,000	-333,000	986,000	874,000	518,000
net cash from operating activities	133,504,000	11,477,000	116,701,000	163,129,000	171,148,000	-321,285,000	116,304,000	137,858,000	163,770,000	44,408,000	113,544,000	41,036,000	149,202,000	76,787,000	97,846,000	110,117,000	90,477,000	76,037,000	186,567,000	207,296,000	219,398,000	45,546,000	119,375,000	84,843,000	85,013,000	43,673,000	127,897,000	68,869,000	144,964,000	72,350,000	128,226,000	83,745,000	130,592,000	57,014,000	101,821,000	76,799,000	124,194,000	58,664,000	98,318,000	50,944,000	72,919,000	18,222,000	39,807,000	21,893,000	7,346,000	20,687,000	16,925,000	27,783,000	167,000	10,563,000	12,789,000	5,611,000	4,935,000	-28,235,000
investing activities:
cash paid for acquisitions, net of cash acquired	429,000	-8,594,000	0	-2,828,000	-369,000	-50,353,000	0																-777,000	0	-4,500,000	-40,400,000									-170,000	0	-103,189,000	-580,096,000	-183,561,000	-104,482,000	-237,116,000	-49,618,000	-712,797,000	0	-10,000,000	-28,414,000	-13,874,000	-99,356,000	-22,375,000	-277,492,000	-75,515,000	-66,000	-90,400,000	-28,365,000
cash paid for capital expenditures	-167,747,000	-174,631,000	-203,494,000	-190,239,000	-154,242,000	-142,410,000	-138,723,000	-128,051,000	-90,834,000	-66,525,000	-87,357,000	-76,348,000	-81,917,000	-50,527,000	-88,187,000	-43,671,000	-54,271,000	-58,682,000	-20,781,000	-63,754,000	-62,533,000	-69,547,000	-81,960,000	-63,594,000	-69,880,000	-69,248,000	-91,473,000	-88,434,000	-91,228,000	-70,327,000	-80,360,000	-76,296,000	-66,972,000	-50,549,000	-57,511,000	-72,243,000	-87,629,000	-90,089,000	-75,206,000	-78,806,000	-69,156,000	-52,879,000	-27,357,000	-21,674,000	-21,649,000	-18,263,000	-20,969,000	-16,945,000	-12,764,000	-13,084,000	-6,892,000	-3,708,000	-3,911,000	-2,781,000
proceeds from sale of property and equipment	16,580,000	43,000	208,000	18,000	1,153,000	9,056,000	28,789,000	12,000	212,000	409,000	5,290,000	110,000	380,000	1,294,000	1,701,000	893,000	765,000	134,000	-2,417,000	1,097,000	1,205,000	207,000
net cash from investing activities	-150,783,000	-183,238,000	-203,330,000	-193,051,000	-155,484,000	-184,614,000	-110,168,000	-129,373,000	-90,768,000	-66,910,000	-92,020,000	-78,024,000	-86,093,000	-49,693,000	-227,265,000	-74,226,000	-49,479,000	1,368,603,000	-72,185,000	-69,722,000	-65,771,000	-74,161,000	-63,949,000	40,790,000	-67,881,000	-110,101,000	-98,470,000	-88,745,000	-95,063,000	-78,686,000	-103,350,000	-86,867,000	-88,214,000	-58,095,000	311,440,000	-81,787,000	-204,571,000	-685,447,000	-267,625,000	-203,260,000	-308,984,000	-104,602,000	-729,107,000	-24,164,000	-47,924,000	-50,931,000	-36,094,000	-120,681,000	-35,272,000	-294,638,000	-119,435,000	-16,348,000	-94,223,000	-37,753,000
financing activities:
borrowings on long-term debt	0	1,200,000,000	0	0	0	350,000,000									0	0	0	425,000,000	475,000,000	0															0	0	0	1,480,000,000	0	275,000,000	0	875,000,000	300,000,000	0	7,500,000	0	0	0	150,000,000	151,063,000	0	0	25,000,000	147,485,000
borrowings on revolving credit facility	70,000,000	760,000,000	95,000,000	50,000,000	0	160,000,000	0	0	0	40,000,000					70,000,000	0	0	430,000,000	0	0			0	0	5,000,000	71,573,000									0	21,000,000	100,000,000	58,000,000	158,000,000	130,000,000	87,000,000	93,000,000	171,000,000	19,000,000	40,500,000
principal payments on revolving credit facility	0	-1,035,000,000	0	0	0	-15,000,000	0	-15,000,000			-10,000,000	0	-75,000,000	-10,000,000	0	-25,000,000	-35,000,000	-270,000,000	0	0			0	-65,000,000											-171,000,000								-7,000,000
principal payments on long-term debt			-15,363,000	-15,363,000	-15,363,000	-10,242,000	-5,312,000	-5,313,000	-5,312,000	-5,313,000	-5,313,000	-5,312,000	-5,313,000	-2,656,000	-2,656,000	-2,657,000			-9,428,000	-10,621,000	-10,621,000	-10,621,000	-28,246,000	-8,246,000	-8,246,000	-8,246,000	-8,246,000	-8,246,000			-8,892,000	-8,638,000	-8,637,000	-8,638,000	-3,872,000	-16,200,000	-16,200,000	-13,669,000	-8,152,000	-7,938,000	-7,937,000	-7,938,000	-1,875,000	-1,875,000	-1,875,000	-2,055,000	-3,750,000	0	-1,875,000	0	-2,000,000	-2,000,000	-2,000,000	-1,688,000
repayment of long-term debt	0	-670,856,000													0	0	-3,332,000	-2,224,603,000	-459,785,000	0																										0	0	0	-52,500,000					0
payment of debt issuance costs	0	-18,615,000	0	0	0	-1,518,000									0	0	1,971,000	-9,935,000	-7,075,000	-625,000															-901,000	-237,000	-1,344,000	-34,167,000	-837,000	-2,809,000	-584,000	-22,191,000	-5,099,000	-2,319,000	-3,491,000	0	0	-154,000	-4,153,000	-3,354,000	-59,000	-90,000	-1,048,000	-6,204,000
repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises	-1,780,000	-1,936,000		844,000	-655,000	-1,013,000		711,000	1,767,000	-47,671,000		2,327,000	1,873,000	-11,741,000
repurchase of common stock	-3,154,000	-46,880,000
contributions from noncontrolling partners in joint ventures			1,680,000	530,000	690,000	2,280,000	420,000	22,000	861,000	1,655,000	2,184,000	5,170,000	3,718,000	4,290,000
distributions to noncontrolling partners in joint ventures			0	-1,472,000	-480,000	-1,020,000	-1,627,000	-1,497,000			0	-157,000	-400,000	-447,000
cash paid for contingent consideration																																											-1,750,000
net cash from financing activities	57,464,000	186,692,000	80,789,000	34,900,000	-15,800,000	483,129,000	-5,654,000	-21,067,000	-24,658,000	-11,318,000	-17,294,000	2,039,000	-75,108,000	-20,540,000	66,919,000	-25,124,000	-34,367,000	-1,648,489,000	-2,935,000	-12,555,000	-22,579,000	-13,430,000	-29,468,000	-74,707,000	-15,955,000	58,503,000	-26,593,000	-10,185,000	-25,818,000	-4,734,000	-32,532,000	-4,319,000	-9,486,000	-13,737,000	-379,312,000	3,013,000	81,171,000	653,969,000	131,263,000	170,575,000	229,160,000	32,604,000	455,175,000	272,772,000	43,252,000	30,779,000	15,804,000	522,000	85,481,000	321,755,000	-1,811,000	130,073,000	29,010,000	125,852,000
net increase in cash and cash equivalents	40,185,000	14,931,000	-5,840,000	4,978,000			482,000	-12,582,000	48,344,000	-33,820,000				6,554,000	-62,500,000	10,767,000			39,995,000	126,763,000			31,292,000	49,359,000			1,582,000	-30,535,000			-8,371,000	-3,773,000	36,347,000	-13,976,000	29,312,000	-2,965,000	-5,866,000	25,367,000		16,190,000	-3,460,000	-56,008,000	-235,565,000	270,501,000	2,674,000			-92,376,000	50,376,000					59,864,000
cash and cash equivalents at beginning of the period	0	76,305,000	0	0	0	100,073,000	0	0	0	97,649,000	0	0	0	133,813,000	0	0	0	378,697,000	0	0	0	124,192,000	0	0	0	50,510,000	0	0	0	67,290,000	0	0	0	57,063,000	0	0	0	11,215,000	0	0	0	94,040,000	0	0	4,569,000	0	0	0	49,399,000	0	0	0	61,118,000	0
cash and cash equivalents at end of the period	40,185,000	91,236,000	-5,840,000	4,978,000	-136,000	77,303,000	482,000	-12,582,000	48,344,000	63,829,000	4,230,000	-34,949,000	-11,999,000	140,367,000	-62,500,000	10,767,000	6,631,000	178,915,000	39,995,000	126,763,000	130,935,000	81,004,000	31,292,000	49,359,000	-143,000	43,684,000	1,582,000	-30,535,000	21,655,000	57,808,000	-8,371,000	-3,773,000	36,347,000	43,087,000	29,312,000	-2,965,000	-5,866,000	36,582,000	-39,547,000	16,190,000	-3,460,000	38,032,000	-235,565,000	270,501,000	7,243,000	535,000	-3,365,000	-92,376,000	99,775,000	37,680,000	-108,457,000	119,336,000	840,000	59,864,000
effect of acquisitions:
assets acquired, excluding cash	113,000	19,768,000	0	3,557,000	369,000	55,309,000	0												-100,000				1,121,000	39,000	4,527,000	44,028,000															207,598,000	1,428,566,000		0	10,500,000		17,644,000	102,732,000	43,330,000		78,968,000	168,000	93,131,000
liabilities assumed	-542,000	-300,000	0	-729,000	0	-3,456,000	0												0				-344,000	-39,000	-27,000	-3,628,000															-11,206,000	-998,738,000					-3,770,000	-3,376,000	-9,271,000		-3,453,000	-102,000	-2,731,000
contingent consideration issued in connection with an acquisition			0	0	0	-1,500,000
redeemable noncontrolling interest resulting from an acquisition	0	-10,874,000					0												100,000
legal settlements		3,504,000
government relief funds							-4,533,000				-6,453,000	-31,405,000	6,344,000	-7,556,000	-26,070,000
repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises
acquisition of ownership interests from noncontrolling partners
supplemental cash flow information:
cash paid for interest
cash paid for income taxes
redeemable noncontrolling interest resulting from acquisition
net decrease in cash and cash equivalents						-22,770,000						-34,949,000						-199,782,000				-43,188,000				-6,826,000				-9,482,000																							-60,278,000
adjustments to reconcile net income to net cash from continuing operating activities:
income from discontinued operations, net of taxes																																									-1,000	-2,000											-311,000
net cash from continuing operating activities											113,544,000	41,036,000	149,202,000	76,787,000	97,846,000	110,117,000	90,477,000	75,784,000					119,375,000	84,843,000	85,013,000	43,673,000	127,897,000	70,845,000	145,249,000	72,637,000	128,658,000	84,177,000	130,996,000	57,439,000	106,553,000	79,350,000	126,548,000	59,283,000	98,574,000	52,977,000	72,499,000	18,088,000	39,823,000	21,935,000	7,315,000	19,914,000	17,108,000	27,874,000	434,000	10,646,000	12,921,000	5,291,000	5,451,000	-27,229,000
net cash from discontinued operating activities															0	0	0	253,000									0	-1,976,000	-285,000	-287,000	-432,000	-432,000	-404,000	-425,000	-4,732,000	-2,551,000	-2,354,000	-619,000	-256,000	-2,033,000	420,000	134,000	-16,000	-42,000	31,000	773,000	-183,000	-91,000	-267,000	-83,000	-132,000	320,000	-516,000	-1,006,000
proceeds from u.k. sale															0	0	0	1,511,020,000
settlement of foreign currency derivatives															0	0	0	-84,795,000					0												0	15,000	-237,000	745,000	0	-1,018,000
cash paid for purchase of finance lease															0
effect of exchange rate changes on cash															0	0	0	4,067,000	3,599,000	1,744,000	-113,000	-1,143,000	5,334,000	-1,567,000	-1,320,000	1,099,000	-1,252,000	-474,000	-2,428,000	1,588,000	-715,000	3,668,000	3,455,000	842,000	-4,637,000	-990,000	-6,660,000	-1,819,000	-1,503,000	-2,069,000	3,445,000	-2,232,000
net cash from continuing investing activities															-227,265,000	-74,226,000	-49,479,000	1,368,603,000																																-294,638,000				-37,745,000
net cash from discontinued investing activities																																																						-8,000
repurchase of shares for payroll tax witholdings, net of proceeds from stock option exercises
net cash from continuing financing activities															66,919,000	-25,124,000	-34,367,000	-1,648,489,000
net cash from discontinued financing activities
net increase in cash and cash equivalents, including cash classified within current assets held for sale															-62,500,000	10,767,000
less: cash classified within current assets held for sale
cash paid (received) for income taxes
loss (income) from discontinued operations, net of taxes															0	0	0	12,641,000																													182,000	74,000	316,000					1,254,000
common stock withheld for minimum statutory taxes															223,000	2,811,000	5,042,000	8,219,000	1,495,000	66,000	25,000	-1,402,000	-151,000	117,000	-288,000	-1,327,000	-1,135,000	-138,000	-104,000	-2,030,000	-177,000	400,000	556,000	-4,234,000	-929,000	-552,000	-686,000	-6,679,000	-180,000	244,000	-2,716,000	-5,110,000	-496,000	-869,000	-2,112,000
distributions to noncontrolling interests															-662,000	-293,000	-256,000	-377,000	-263,000	-202,000	-187,000	-264,000
change in operating assets and liabilities:
net decrease in cash and cash equivalents, including cash classified within current assets held for sale																		-199,782,000
cash paid for real estate acquisitions																			-2,754,000	-1,180,000	-1,266,000	-3,149,000	-642,000	-2,528,000	-3,382,000	-1,066,000	-8,992,000	-534,000	-4,564,000	-4,293,000	-7,760,000	-10,447,000	-20,355,000	-2,495,000	-2,810,000	-9,508,000	-13,640,000	-14,799,000	-4,646,000	-18,548,000	-1,706,000	-1,722,000	-3,921,000	-2,229,000	-16,097,000	-3,416,000	-717,000			-2,414,000	-36,859,000
cash (received) paid for income taxes
loss on divestiture																																			4,070,000
gain on foreign currency derivatives																																						-410,000	0	1,018,000	961,000	-53,000	-1,527,000
cash received on divestitures
repayment of assumed debt																																			0	0	0	-1,348,389,000
issuances of common stock
issuance of common stock in connection with acquisition																																									0	-380,210,000
deferred income tax expense																														1,897,000	1,956,000	12,320,000	15,089,000	2,007,000	2,790,000	9,036,000	7,736,000	9,085,000	14,688,000	4,243,000	5,458,000	19,224,000	-4,452,000	6,866,000	2,231,000	-462,000	5,153,000	2,937,000	2,455,000	-5,291,000	3,284,000	3,308,000	1,546,000	-6,333,000
(income) income from discontinued operations, net of taxes																																							-28,000					6,000	-37,000						138,000
(gain) loss on foreign currency derivatives																																			0	-15,000
payment of premium on senior notes																																							-590,000
excess tax benefit from equity awards																																							-7,711,000	1,693,000	2,017,000	4,310,000	300,000	749,000	2,730,000	514,000	54,000	576,000	635,000
issuance of common stock																																				0	0	685,097,000		-170,000			95,000								-80,000
principal payments revolving credit facility																																					0	-166,000,000		-130,000,000
repayment of senior notes																																							-9,169,000
deposits paid for acquisitions
repayment of assumed crc debt																																							0	0	0	-904,467,000
net increase(decrease) in cash and cash equivalents
prior year deposits paid for acquisitions																																												0	-500,000		0	0	-11,684,000
payment of premium on note redemption																																														0	0	0	-6,759,000
cash distribution paid to equity holders
contribution from holdings																																																						0
distributions to equity holders																																																						0
net increase in revolving credit facility																																																					7,000,000
proceeds from stock option exercises																																															0	100,000	133,000	445,000	328,000	129,000	58,000
benefit from doubtful accounts																																																		960,000	1,502,000
benefit from bad debts																																																					1,723,000	1,562,000
proceeds from issuance of common stock
payment of equity issuance costs
accounts payable
other accrued expenses
cash paid for real estate acquisition

We provide you with 20 years of cash flow statements for Acadia Healthcare stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Acadia Healthcare stock. Explore the full financial landscape of Acadia Healthcare stock with our expertly curated income statements.

The information provided in this report about Acadia Healthcare stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.